126 related articles for article (PubMed ID: 10472325)
1. Thymidine kinase (TK) gene therapy of solid tumors: valacyclovir facilitates outpatient treatment.
Hasenburg A; Tong XW; Rojas-Martinez A; Nyberg-Hoffman C; Kieback CC; Kaplan AL; Kaufman RH; Ramzy I; Aguilar-Cordova E; Kieback DG
Anticancer Res; 1999; 19(3B):2163-5. PubMed ID: 10472325
[TBL] [Abstract][Full Text] [Related]
2. The role of a HSV thymidine kinase stimulating substance, scopadulciol, in improving the efficacy of cancer gene therapy.
Hayashi K; Lee JB; Maitani Y; Toyooka N; Nemoto H; Hayashi T
J Gene Med; 2006 Aug; 8(8):1056-67. PubMed ID: 16779868
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of valacyclovir in the adult horse.
Maxwell LK; Bentz BG; Bourne DW; Erkert RS
J Vet Pharmacol Ther; 2008 Aug; 31(4):312-20. PubMed ID: 18638291
[TBL] [Abstract][Full Text] [Related]
4. Enhanced systemic T-cell activation after in situ gene therapy with radiotherapy in prostate cancer patients.
Satoh T; Teh BS; Timme TL; Mai WY; Gdor Y; Kusaka N; Fujita T; Pramudji CK; Vlachaki MT; Ayala G; Wheeler T; Amato R; Miles BJ; Kadmon D; Butler EB; Thompson TC
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):562-71. PubMed ID: 15145177
[TBL] [Abstract][Full Text] [Related]
5. Improved radiosensitization of rat glioma cells with adenovirus-expressed mutant herpes simplex virus-thymidine kinase in combination with acyclovir.
Valerie K; Brust D; Farnsworth J; Amir C; Taher MM; Hershey C; Feden J
Cancer Gene Ther; 2000 Jun; 7(6):879-84. PubMed ID: 10880018
[TBL] [Abstract][Full Text] [Related]
6. Suicide gene therapy toxicity after multiple and repeat injections in patients with localized prostate cancer.
Shalev M; Kadmon D; Teh BS; Butler EB; Aguilar-Cordova E; Thompson TC; Herman JR; Adler HL; Scardino PT; Miles BJ
J Urol; 2000 Jun; 163(6):1747-50. PubMed ID: 10799174
[TBL] [Abstract][Full Text] [Related]
7. Persistent adenovirus-mediated thymidine kinase gene expression in ovarian cancer cells increases cell killing efficacy over time.
Kieback DG; Delvoux B; Romano A; Ollig S; Fischer DC
Anticancer Res; 2008; 28(5A):2569-75. PubMed ID: 19035280
[TBL] [Abstract][Full Text] [Related]
8. Thymidine kinase gene therapy with concomitant topotecan chemotherapy for recurrent ovarian cancer.
Hasenburg A; Tong XW; Rojas-Martinez A; Nyberg-Hoffman C; Kieback CC; Kaplan A; Kaufman RH; Ramzy I; Aguilar-Cordova E; Kieback DG
Cancer Gene Ther; 2000 Jun; 7(6):839-44. PubMed ID: 10880013
[TBL] [Abstract][Full Text] [Related]
9. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
Teh BS; Ayala G; Aguilar L; Mai WY; Timme TL; Vlachaki MT; Miles B; Kadmon D; Wheeler T; Caillouet J; Davis M; Carpenter LS; Lu HH; Chiu JK; Woo SY; Thompson T; Aguilar-Cordova E; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1520-9. PubMed ID: 15050332
[TBL] [Abstract][Full Text] [Related]
10. Effects of anti herpetic drugs on mice with herpetic epithelial keratitis after reactivation of herpes simplex virus type 1.
Itahashi M; Higaki S; Shimomura Y
Semin Ophthalmol; 2008; 23(4):241-7. PubMed ID: 18584562
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus-mediated herpes simplex virus thymidine kinase gene therapy in BT4C rat glioma model.
Tyynelä K; Sandmair AM; Turunen M; Vanninen R; Vainio P; Kauppinen R; Johansson R; Vapalahti M; Ylä-Herttuala S
Cancer Gene Ther; 2002 Nov; 9(11):917-24. PubMed ID: 12386830
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of valacyclovir for the suppression and episodic treatment of herpes simplex virus in patients with HIV.
Warren T; Harris J; Brennan CA
Clin Infect Dis; 2004 Nov; 39 Suppl 5():S258-66. PubMed ID: 15494897
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of valacyclovir vs acyclovir for the prevention of recurrent herpes simplex virus eye disease: a pilot study.
Miserocchi E; Modorati G; Galli L; Rama P
Am J Ophthalmol; 2007 Oct; 144(4):547-51. PubMed ID: 17692271
[TBL] [Abstract][Full Text] [Related]
14. [Adenovirus-mediated herpes simplex virus thymidine kinase gene transference and combined drug therapy leads to apoptosis of human epithelial ovarian cancer cells].
Jiang J; Kong B; Jiang S
Zhonghua Fu Chan Ke Za Zhi; 2000 Dec; 35(12):736-9. PubMed ID: 11286034
[TBL] [Abstract][Full Text] [Related]
15. Pronounced cytostatic activity and bystander effect of a novel series of fluorescent tricyclic acyclovir and ganciclovir derivatives in herpes simplex virus thymidine kinase gene-transduced tumor cell lines.
Balzarini J; Ostrowski T; Goslinski T; De Clercq E; Golankiewicz B
Gene Ther; 2002 Sep; 9(17):1173-82. PubMed ID: 12170381
[TBL] [Abstract][Full Text] [Related]
16. Clinical utility of oral valacyclovir compared with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or stem cell rescue therapy.
Eisen D; Essell J; Broun ER; Sigmund D; DeVoe M
Bone Marrow Transplant; 2003 Jan; 31(1):51-5. PubMed ID: 12621507
[TBL] [Abstract][Full Text] [Related]
17. Substantially improved in vivo radiosensitization of rat glioma with mutant HSV-TK and acyclovir.
Valerie K; Hawkins W; Farnsworth J; Schmidt-Ullrich R; Lin PS; Amir C; Feden J
Cancer Gene Ther; 2001 Jan; 8(1):3-8. PubMed ID: 11219491
[TBL] [Abstract][Full Text] [Related]
18. Valacyclovir in the treatment of facial herpes simplex virus infection.
Laiskonis A; Thune T; Neldam S; Hiltunen-Back E
J Infect Dis; 2002 Oct; 186 Suppl 1():S66-70. PubMed ID: 12353189
[TBL] [Abstract][Full Text] [Related]
19. Progress report on phase I/II clinical trial of Ad-OC-TK plus VAL therapy for metastatic or locally recurrent prostate cancer: Initial experience at Kobe University.
Hinata N; Shirakawa T; Terao S; Goda K; Tanaka K; Yamada Y; Hara I; Kamidono S; Fujisawa M; Gotoh A
Int J Urol; 2006 Jun; 13(6):834-7. PubMed ID: 16834676
[TBL] [Abstract][Full Text] [Related]
20. Comparison of oral antiviral therapy with valacyclovir or acyclovir after penetrating keratoplasty for herpetic keratitis.
Goldblum D; Bachmann C; Tappeiner C; Garweg J; Frueh BE
Br J Ophthalmol; 2008 Sep; 92(9):1201-5. PubMed ID: 18650215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
